Register Now - Next Steps Workshop to explore the science, manufacturing & quality components of generics + biosimilars.

Capitol Hill Briefing

Patient Access to Affordable Medicines: How a Renegotiated NAFTA Could Keep Drug Prices High

Watch Stream
Next Steps: Manufacturing and Quality Workshop

Join AAM and USP in this workshop, which explores the science, manufacturing and quality components of generics and biosimilars.

Register Now
Patients Can See Their Savings

For the first time ever, the Association for Accessible Medicines is releasing savings data for 20 common patient conditions.

Learn More
Preserve Patient Access in Trade Agreements

Extending monopolies for brand-name drugs in trade agreements only increases patient drug prices. How? The new NAFTA deal decreases drug price competition.

Learn More
New Report

The 10th edition of the Generic Drug Access & Savings in the United States report.

Read 2018 Report
Skyrocketing Drug Prices Are a Threat to Everyone

Use this infographic to learn how generics and biosimilars are a remedy to sky-high health care costs.

Read Blog

Working to leave a positive impact on...

Industry

We promote competition in the pharmaceutical industry by lowering barriers to entry for manufacturers and combatting anti-competitive abuses by some brand drug companies who put profits before patients. Learn More

People

We measure our success as an industry by the lives we impact. We work to protect the low cost of current drugs and to drive down the cost of developing new ones, expanding access to as many people as possible. Learn More

Society

We are a trusted partner and established authority within the pharmaceutical field. We provide accurate, timely data to educate policymakers and promote general public knowledge regarding the positive impact of affordable medicines. Learn More

About Us

The Association for Accessible Medicines, formerly the Generic Pharmaceutical Association, improves access to safe, quality, effective medicine. Better access to medicine is relevant to everybody because, after all, we’re all patients at some point.

Health is the foundation for everything in life. Healthy people are better able to reach their full potential. Generics and biosimilars help more people in more places live healthier and longer.

Recent Updates

Aug 30, 2018 | Jewel Smith

Four Reasons Why – The Benefits of AAM Membership

New NAFTA - North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Aug 28, 2018 | Rachel Schwartz

North American Generic Drugmakers Call for Rejection of New Exclusivity Period for Biologics

Video

Aug 16, 2018 | Erica Klinger

Overview of the EverFi Prescription Drug Abuse Prevention Digital Course

Video

Aug 16, 2018 | Allen Goldberg

EverFi Opioid Abuse Prevention Education Program — underwritten by AAM

Video

Aug 14, 2018 | Erica Klinger

Christine Simmon: GRx+Biosims Combines Three Events into One

FDA's Competitive Generic Therapy (CGT) Designation

Aug 8, 2018 | Rachel Schwartz

AAM Statement in Response to FDA's Competitive Generic Therapy (CGT) Designation